Longevity SF + ODLB Meetup

​Longevity SF is teaming up with ODLB for a meetup. We will discuss the newly approved Alzheimer's drug over drinks. Parts of the meetup will be live streamed- let one of your hosts at the event know if you do not want to be on video or in pictures on the socials and we will position you away from the camera.

About Longevity SF- we are a non-profit organization that connects longevity researchers, investors, and entrepreneurs for collaboration and community building. You can find us at https://longevitysf.org/ and @longevitysf.

About ODLB- On Deck Longevity Biotech (ODLB) is a continuous community for people to come together to build, join, or invest in revolutionary longevity biotechnology startups. You can find us here https://www.beondeck.com/longevity-biotech and @OnDeckLongevity.

Tickets are free for Longevity SF sustaining members. Apply to join Longevity SF here: https://longevitysf.org/join/.

​Students and postdocs get $10 off with code STUDENT/POSTDOC
Free for ODLB fellows with code "ODLB"

​Reading list for the event:

• ​Five big questions about the new Alzheimer’s treatment

• ​Death of patient in closely watched Alzheimer’s trial raises concern about risk for some groups

• ​Alzheimer's, Adhuhelm, and the amyloid hypothesis. 

• ​Faked Beta-Amyloid Data. What Does It Mean?

​
We are going to have Dr. Priyanka Joshi, biophysicist and aggregation expert, at the event tomorrow talking all the nitty gritty details of amyloid. She and I (Christin) come from slightly different povs on amyloid so should get fun. She would like to recommend this paper: https://www.biorxiv.org/content/10.1101/2022.11.08.515609v1